What podcasts say about GLP-1
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about GLP-1
25 statements · 15 positive · 9 negative · 1 mixed
Direct-to-consumer GLP-1 access can lower prices while increasing drugmaker revenue
“Prices go from $1,300 to $149. and the people making the drugs are making more money.”
Open the episode · Zach Reitano - Building Ro and Why Healthcare Should Be 50% of GDP - [Invest Like the Best, EP.500]Listen at 8:30
GLP-1 inventors should capture more margin than access providers
“the inventors of GLP-1s should grab more margin than the people who scale access to debt.”
Open the episode · Zach Reitano - Building Ro and Why Healthcare Should Be 50% of GDP - [Invest Like the Best, EP.500]Listen at 14:58
GLP-1 prices fell approximately 90% after Hims & Hers began compounding products.
“Since that, since hims and hers started compounding, the price of GLP ones is down around 90%.”
Open the episode · The AI Market Crash Is Here; Reddit, Axon, And Uber Earnings; Asymmetric Stocks With Travis HoiumListen at 38:37
New technologies such as GLP-1 drugs will prevent major healthcare-cost declines.
“i can't see healthcare costs coming down so much because there will be new technologies like glp ones that people want to spend money on”
Open the episode · Bitcoin Is the Hedge Against a U.S. Default Nobody Sees Coming | Jan Van EckListen at 18:09
- Daniel MüllerMixedNov 5, 2026· The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network
Daniel Müller is increasingly uncertain about GLP-1 drugs’ business impact.
“the more I learn about them, the more uncertain I am.”
Open the episode · TIP858: McDonald's ($MCD): Generational Compounder in Historical Drawdown w/ Daniel Mahncke & Shawn O'MalleyListen at 49:34
- Shawn O'MearaNegativeNov 5, 2026· The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network
GLP-1 drugs pose a growing global challenge to McDonald’s.
“this gives a whole lot more reason to believe that this is a challenge that's not going to fade away for McDonald's and will only continue to grow globally”
Open the episode · TIP858: McDonald's ($MCD): Generational Compounder in Historical Drawdown w/ Daniel Mahncke & Shawn O'MalleyListen at 58:37
- Daniel MüllerNegativeNov 5, 2026· The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network
GLP-1 drugs may be McDonald’s most powerful threat in decades.
“that's probably the most powerful threat that we have had McDonald's seeing in probably decades, if not ever.”
Open the episode · TIP858: McDonald's ($MCD): Generational Compounder in Historical Drawdown w/ Daniel Mahncke & Shawn O'MalleyListen at 59:12
People taking GLP-1 drugs typically lose approximately equal amounts of fat and muscle.
“typically speaking, about 50% of the weight that someone loses is fat and 50% muscle.”
Open the episode · WHOOP CEO, Will Ahmed: 50B Hours of Health Data, a 4 Million Member Data Moat, & the FDA FightListen at 33:07
Craig Fuller reports losing 50 pounds while taking a GLP-1 medication.
“I've lost 50 pounds”
Open the episode · "No Signs Of The A.I. Party Slowing Down" | Craig FullerListen at 10:55
GLP-1 medications are likely affecting fine-dining consumption patterns.
“I'm sure it is affecting”
Open the episode · How a Chicago Restaurant Has Stayed Open For Nearly Three DecadesListen at 42:13
Peripheral and central GLP-1 independently suppress hunger.
“The peripheral GLP-1 and the central GLP-1 have very similar effects. So they're involved in hunger suppression, but they seem to be operating independently.”
Open the episode · How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott KanoskiListen at 4:05
Peripheral and central GLP-1 both suppress appetite
“But they do both have appetite suppressing effects.”
Open the episode · How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott KanoskiListen at 4:21
GLP-1 regulates blood glucose and stimulates insulin secretion during hyperglycemia.
“they're helping to regulate blood glucose levels, to stimulate insulin secretion when there's high levels of glucose present in the blood.”
Open the episode · How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott KanoskiListen at 4:28
GLP-1 promotes satiation largely through vagal paracrine signaling.
“GLP-1 is a big player in that process. Not exclusively through the vagus nerve, but probably largely through the vagus nerve, through this paracrine mode of action.”
Open the episode · How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott KanoskiListen at 15:24
Generic competition will emerge for GLP-1s in some markets
“generic competition is going to start coming quite soon”
Open the episode · Novo Nordisk Drops, Puma Down, Trainline RisesListen at 1:05
Cheaper GLP-1 generics could become a major tailwind for retailers.
“as the competition heats up as when generics eventually hit the market they're already hitting the market in countries like brazil this is going to be a huge potential tailwind for the retailers”
Open the episode · Macy’s Falls on Guidance Despite Sales Beat, Better OutlookListen at 5:24
Cheaper and generic GLP-1 drugs could strongly benefit retailers.
“this is going to be a huge potential tailwind for the retailers”
Open the episode · Macy’s Falls on Guidance Despite Sales Beat, Better OutlookListen at 5:30
GLP-1 drugs will be effective for COPD.
“I do think GOP-1 is going to be really good on COPD.”
Open the episode · 'Mad Money w/ Jim Cramer 9/8/26Listen at 39:19
GLP-1 medicines will continue expanding strongly
“the GLP ones, they're clearly just going to continue to power on”
Open the episode · Knowing when to sell: How growth investor Michael Frazis manages riskListen at 39:41
GLP-1 product penetration increased significantly over the past year
“Penetration for GLP One products have been increasing significantly, I would say, in the past year”
Open the episode · Meta Says It Will Pay Up to $18 Billion Over Social Media ClaimsListen at 30:24
GLP-1 adoption has created headwinds for food companies
“definitely they have been some headwinds”
Open the episode · Meta Says It Will Pay Up to $18 Billion Over Social Media ClaimsListen at 30:56
Obesity rates are falling slightly, partly because of GLP-1 drugs.
“We're seeing obesity rates falling, although only slightly because of GLP-1s.”
Open the episode · David Wallace-Wells: The Politics of AI Are Shifting in Real TimeListen at 54:06
GLP-1 peptides have stronger clinical effects than obscure peptides lacking clear targets.
“the GLP1s, which have a very strong clinical effect compared to these obscure peptides like BBC157, TB500, TB4, that don't have a clear target.”
Open the episode · Peptides: The Science, Uses & Safety | Dr. Abud BakriListen at 4:46
Waters supplies separation columns used in quality control by major GLP-1 manufacturers.
“For both of the large GLP-1 manufacturers, our columns are used in quality control.”
Open the episode · Mad Money w/ Jim Cramer 5/5/26Listen at 29:59
GLP-1 drugs from Eli Lilly and Novo Nordisk have severely harmed sleep-apnea investments.
“anything related to sleep apnea has been eviscerated by the rise of the GOP-1 weight loss drugs from Eli Lilly and Novo Nordics.”
Open the episode · Mad Money w/ Jim Cramer 10/6/25Listen at 28:53
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.